Evaluation of the Intubating Laryngeal Airway in Children

University of British Columbia logo

University of British Columbia

Status and phase

Completed
Phase 3

Conditions

Intubating Laryngeal Airway

Treatments

Device: AirQ Intubating Laryngeal Airway

Study type

Interventional

Funder types

Other

Identifiers

NCT01029431
H08-02199

Details and patient eligibility

About

The Air-Q® intubating laryngeal airway (Air-Q® ILA) is an extraglottic device specifically engineered for use both as a stand-alone laryngeal mask airway (LMA) and as a rescue device or "Plan B" device in the event of a difficult airway. As with some other types of LMA, it is then possible to insert an endotracheal tube (ETT) through the Air-Q® ILA, either blindly or mounted on a fibreoptic bronchoscope (FOB), to achieve endotracheal intubation. The objective of this study is to compare the Air-Q® ILA's performance to the current best option, the PLMA.

Full description

Hypothesis: The hypothesis is that, for each of the four ILA size categories, 1.0, 1.5, 2.0 & 2.5: H0: Mean oropharyngeal leak pressure with Air-Q® ILA= mean oropharyngeal leak pressure with PLMA. H1: Mean oropharyngeal leak pressure with Air-Q® ILA≠ mean oropharyngeal leak pressure with PLMA. Background: The laryngeal mask airway (LMA) is used during pediatric anesthesia for routine and difficult airway management. The ideal pediatric LMA device would provide excellent sealing at low pressure; facilitate easy endotracheal intubation; and be available in pediatric sizes. Such a device would be an invaluable addition to difficult pediatric airway management plans and, by increasing the likelihood of quickly and effectively securing the difficult airway, and decreasing the risk of catastrophic hypoxemia, would increase perioperative safety for children. The Air-Q® ILA is a modified LMA device whose features encompass the characteristics of the ideal LMA. Our objective is to determine whether or not this new airway device is an improvement over the current standard of care. Specific Objectives: The objective of this study is to compare the Air-Q® ILA's performance to the current best option, the PLMA. Methods: Recruitment of subjects: With ethical and institutional review board approval, and with written parental informed consent, we will recruit children undergoing elective surgery. Children with ASA status IV-V, abnormal or contraindicated cervical spine flexion/extension/rotation, contraindication to LMA placement, or requiring emergency surgery will be excluded. All children will undergo intravenous induction of anesthesia, as per our routine institutional practice. Administration of Air-Q® ILA: In phase 2, either a PLMA or an Air-Q® ILA will be inserted and assessed. The first LMA will then be removed and the other device inserted and assessed. The order of insertion will be determined by block randomization. Data analysis: In phase 2, we will compare OLP values using paired t- tests. We will conduct appropriate statistical analysis of the data on the other assessment variables, which are all secondary outcome measures. Descriptive data will be presented as mean ± SD, median (range), counts (percentages or proportions) as appropriate.

Enrollment

90 patients

Sex

All

Ages

Under 16 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Eligibility Key inclusion and exclusion criteria Inclusion:

  • ASA I-III
  • Ideal body weight as determined from weight/height centile curves (>3rd & <97th centiles).
  • Elective surgery
  • Appropriate subject and procedure for airway management by LMA sizes 1, 1.5, 2 or 2.5 (Weight 0-50 kg).

Exclusion criteria

  • ASA status IV-V
  • Emergency surgery
  • Abnormal or contraindicated cervical spine flexion/extension/rotation
  • Contraindication to LMA placement
  • Aspiration risk; gastro-oesophageal reflux disease
  • Clinically significant pulmonary disease
  • Coagulopathy
  • Distorted airway anatomy judged likely to compromise LMA placement
  • Allergy to any LMA components.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

90 participants in 1 patient group

1
Experimental group
Description:
All subjects will have both Air-Q ILA & PLMA
Treatment:
Device: AirQ Intubating Laryngeal Airway

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems